Association of Serum Bile Acids Profile and Pathway Dysregulation With the Risk of Developing Diabetes Among Normoglycemic Chinese Adults: Findings From the 4C Study

Comprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA profile and coregulation with the risk of developing type 2 diabetes mellitus (T2DM) among normoglycemic Chinese adults. We tested 23 serum BA species in...

Full description

Saved in:
Bibliographic Details
Published inDiabetes care Vol. 44; no. 2; pp. 499 - 510
Main Authors Lu, Jieli, Wang, Shuangyuan, Li, Mian, Gao, Zhengnan, Xu, Yu, Zhao, Xinjie, Hu, Chunyan, Zhang, Yi, Liu, Ruixin, Hu, Ruying, Shi, Lixin, Zheng, Ruizhi, Du, Rui, Su, Qing, Wang, Jiqiu, Chen, Yuhong, Yu, Xuefeng, Yan, Li, Wang, Tiange, Zhao, Zhiyun, Wang, Xiaolin, Li, Qi, Qin, Guijun, Wan, Qin, Chen, Gang, Xu, Min, Dai, Meng, Zhang, Di, Tang, Xulei, Wang, Guixia, Shen, Feixia, Luo, Zuojie, Qin, Yingfen, Chen, Li, Huo, Yanan, Li, Qiang, Ye, Zhen, Zhang, Yinfei, Liu, Chao, Wang, Youmin, Wu, Shengli, Yang, Tao, Deng, Huacong, Li, Donghui, Lai, Shenghan, Mu, Yiming, Chen, Lulu, Zhao, Jiajun, Xu, Guowang, Ning, Guang, Bi, Yufang, Wang, Weiqing
Format Journal Article
LanguageEnglish
Published United States American Diabetes Association 01.02.2021
Subjects
Online AccessGet full text
ISSN0149-5992
1935-5548
1935-5548
DOI10.2337/dc20-0884

Cover

Abstract Comprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA profile and coregulation with the risk of developing type 2 diabetes mellitus (T2DM) among normoglycemic Chinese adults. We tested 23 serum BA species in subjects with incident diabetes ( = 1,707) and control subjects ( = 1,707) matched by propensity score (including age, sex, BMI, and fasting glucose) from the China Cardiometabolic Disease and Cancer Cohort (4C) Study, which was composed of 54,807 normoglycemic Chinese adults with a median follow-up of 3.03 years. Multivariable-adjusted odds ratios (ORs) for associations of BAs with T2DM were estimated using conditional logistic regression. In multivariable-adjusted logistic regression analysis, per SD increment of unconjugated primary and secondary BAs were inversely associated with incident diabetes, with an OR (95% CI) of 0.89 (0.83-0.96) for cholic acid, 0.90 (0.84-0.97) for chenodeoxycholic acid, and 0.90 (0.83-0.96) for deoxycholic acid ( < 0.05 and false discovery rate <0.05). On the other hand, conjugated primary BAs (glycocholic acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, and sulfated glycochenodeoxycholic acid) and secondary BA (tauroursodeoxycholic acid) were positively related with incident diabetes, with ORs ranging from 1.11 to 1.19 (95% CIs ranging between 1.05 and 1.28). In a fully adjusted model additionally adjusted for liver enzymes, HDL cholesterol, diet, 2-h postload glucose, HOMA-insulin resistance, and waist circumference, the risk estimates were similar. Differential correlation network analysis revealed that perturbations in intraclass (i.e., primary and secondary) and interclass (i.e., unconjugated and conjugated) BA coregulation preexisted before diabetes onset. These findings reveal novel changes in BAs exist before incident T2DM and support a potential role of BA metabolism in the pathogenesis of diabetes.
AbstractList Comprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA profile and coregulation with the risk of developing type 2 diabetes mellitus (T2DM) among normoglycemic Chinese adults.OBJECTIVEComprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA profile and coregulation with the risk of developing type 2 diabetes mellitus (T2DM) among normoglycemic Chinese adults.We tested 23 serum BA species in subjects with incident diabetes (n = 1,707) and control subjects (n = 1,707) matched by propensity score (including age, sex, BMI, and fasting glucose) from the China Cardiometabolic Disease and Cancer Cohort (4C) Study, which was composed of 54,807 normoglycemic Chinese adults with a median follow-up of 3.03 years. Multivariable-adjusted odds ratios (ORs) for associations of BAs with T2DM were estimated using conditional logistic regression.RESEARCH DESIGN AND METHODSWe tested 23 serum BA species in subjects with incident diabetes (n = 1,707) and control subjects (n = 1,707) matched by propensity score (including age, sex, BMI, and fasting glucose) from the China Cardiometabolic Disease and Cancer Cohort (4C) Study, which was composed of 54,807 normoglycemic Chinese adults with a median follow-up of 3.03 years. Multivariable-adjusted odds ratios (ORs) for associations of BAs with T2DM were estimated using conditional logistic regression.In multivariable-adjusted logistic regression analysis, per SD increment of unconjugated primary and secondary BAs were inversely associated with incident diabetes, with an OR (95% CI) of 0.89 (0.83-0.96) for cholic acid, 0.90 (0.84-0.97) for chenodeoxycholic acid, and 0.90 (0.83-0.96) for deoxycholic acid (P < 0.05 and false discovery rate <0.05). On the other hand, conjugated primary BAs (glycocholic acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, and sulfated glycochenodeoxycholic acid) and secondary BA (tauroursodeoxycholic acid) were positively related with incident diabetes, with ORs ranging from 1.11 to 1.19 (95% CIs ranging between 1.05 and 1.28). In a fully adjusted model additionally adjusted for liver enzymes, HDL cholesterol, diet, 2-h postload glucose, HOMA-insulin resistance, and waist circumference, the risk estimates were similar. Differential correlation network analysis revealed that perturbations in intraclass (i.e., primary and secondary) and interclass (i.e., unconjugated and conjugated) BA coregulation preexisted before diabetes onset.RESULTSIn multivariable-adjusted logistic regression analysis, per SD increment of unconjugated primary and secondary BAs were inversely associated with incident diabetes, with an OR (95% CI) of 0.89 (0.83-0.96) for cholic acid, 0.90 (0.84-0.97) for chenodeoxycholic acid, and 0.90 (0.83-0.96) for deoxycholic acid (P < 0.05 and false discovery rate <0.05). On the other hand, conjugated primary BAs (glycocholic acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, and sulfated glycochenodeoxycholic acid) and secondary BA (tauroursodeoxycholic acid) were positively related with incident diabetes, with ORs ranging from 1.11 to 1.19 (95% CIs ranging between 1.05 and 1.28). In a fully adjusted model additionally adjusted for liver enzymes, HDL cholesterol, diet, 2-h postload glucose, HOMA-insulin resistance, and waist circumference, the risk estimates were similar. Differential correlation network analysis revealed that perturbations in intraclass (i.e., primary and secondary) and interclass (i.e., unconjugated and conjugated) BA coregulation preexisted before diabetes onset.These findings reveal novel changes in BAs exist before incident T2DM and support a potential role of BA metabolism in the pathogenesis of diabetes.CONCLUSIONSThese findings reveal novel changes in BAs exist before incident T2DM and support a potential role of BA metabolism in the pathogenesis of diabetes.
OBJECTIVE Comprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA profile and coregulation with the risk of developing type 2 diabetes mellitus (T2DM) among normoglycemic Chinese adults. RESEARCH DESIGN AND METHODS We tested 23 serum BA species in subjects with incident diabetes (n = 1,707) and control subjects (n = 1,707) matched by propensity score (including age, sex, BMI, and fasting glucose) from the China Cardiometabolic Disease and Cancer Cohort (4C) Study, which was composed of 54,807 normoglycemic Chinese adults with a median follow-up of 3.03 years. Multivariable-adjusted odds ratios (ORs) for associations of BAs with T2DM were estimated using conditional logistic regression. RESULTS In multivariable-adjusted logistic regression analysis, per SD increment of unconjugated primary and secondary BAs were inversely associated with incident diabetes, with an OR (95% CI) of 0.89 (0.83–0.96) for cholic acid, 0.90 (0.84–0.97) for chenodeoxycholic acid, and 0.90 (0.83–0.96) for deoxycholic acid (P < 0.05 and false discovery rate <0.05). On the other hand, conjugated primary BAs (glycocholic acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, and sulfated glycochenodeoxycholic acid) and secondary BA (tauroursodeoxycholic acid) were positively related with incident diabetes, with ORs ranging from 1.11 to 1.19 (95% CIs ranging between 1.05 and 1.28). In a fully adjusted model additionally adjusted for liver enzymes, HDL cholesterol, diet, 2-h postload glucose, HOMA-insulin resistance, and waist circumference, the risk estimates were similar. Differential correlation network analysis revealed that perturbations in intraclass (i.e., primary and secondary) and interclass (i.e., unconjugated and conjugated) BA coregulation preexisted before diabetes onset. CONCLUSIONS These findings reveal novel changes in BAs exist before incident T2DM and support a potential role of BA metabolism in the pathogenesis of diabetes.
Comprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA profile and coregulation with the risk of developing type 2 diabetes mellitus (T2DM) among normoglycemic Chinese adults. We tested 23 serum BA species in subjects with incident diabetes ( = 1,707) and control subjects ( = 1,707) matched by propensity score (including age, sex, BMI, and fasting glucose) from the China Cardiometabolic Disease and Cancer Cohort (4C) Study, which was composed of 54,807 normoglycemic Chinese adults with a median follow-up of 3.03 years. Multivariable-adjusted odds ratios (ORs) for associations of BAs with T2DM were estimated using conditional logistic regression. In multivariable-adjusted logistic regression analysis, per SD increment of unconjugated primary and secondary BAs were inversely associated with incident diabetes, with an OR (95% CI) of 0.89 (0.83-0.96) for cholic acid, 0.90 (0.84-0.97) for chenodeoxycholic acid, and 0.90 (0.83-0.96) for deoxycholic acid ( < 0.05 and false discovery rate <0.05). On the other hand, conjugated primary BAs (glycocholic acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, and sulfated glycochenodeoxycholic acid) and secondary BA (tauroursodeoxycholic acid) were positively related with incident diabetes, with ORs ranging from 1.11 to 1.19 (95% CIs ranging between 1.05 and 1.28). In a fully adjusted model additionally adjusted for liver enzymes, HDL cholesterol, diet, 2-h postload glucose, HOMA-insulin resistance, and waist circumference, the risk estimates were similar. Differential correlation network analysis revealed that perturbations in intraclass (i.e., primary and secondary) and interclass (i.e., unconjugated and conjugated) BA coregulation preexisted before diabetes onset. These findings reveal novel changes in BAs exist before incident T2DM and support a potential role of BA metabolism in the pathogenesis of diabetes.
Author Zheng, Ruizhi
Tang, Xulei
Liu, Chao
Yang, Tao
Xu, Min
Lu, Jieli
Wan, Qin
Chen, Li
Huo, Yanan
Wang, Tiange
Chen, Lulu
Wang, Xiaolin
Qin, Guijun
Zhang, Yinfei
Deng, Huacong
Zhao, Xinjie
Shen, Feixia
Du, Rui
Wang, Shuangyuan
Bi, Yufang
Liu, Ruixin
Ye, Zhen
Luo, Zuojie
Dai, Meng
Wang, Youmin
Zhao, Jiajun
Li, Qi
Lai, Shenghan
Wu, Shengli
Zhang, Yi
Hu, Ruying
Wang, Guixia
Zhao, Zhiyun
Chen, Gang
Wang, Jiqiu
Chen, Yuhong
Li, Donghui
Shi, Lixin
Su, Qing
Zhang, Di
Xu, Guowang
Ning, Guang
Xu, Yu
Yan, Li
Hu, Chunyan
Wang, Weiqing
Li, Qiang
Gao, Zhengnan
Qin, Yingfen
Mu, Yiming
Yu, Xuefeng
Li, Mian
Author_xml – sequence: 1
  givenname: Jieli
  orcidid: 0000-0003-1317-0896
  surname: Lu
  fullname: Lu, Jieli
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 2
  givenname: Shuangyuan
  surname: Wang
  fullname: Wang, Shuangyuan
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 3
  givenname: Mian
  surname: Li
  fullname: Li, Mian
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 4
  givenname: Zhengnan
  surname: Gao
  fullname: Gao, Zhengnan
  organization: Dalian Municipal Central Hospital, Dalian, China
– sequence: 5
  givenname: Yu
  surname: Xu
  fullname: Xu, Yu
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 6
  givenname: Xinjie
  surname: Zhao
  fullname: Zhao, Xinjie
  organization: Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China
– sequence: 7
  givenname: Chunyan
  orcidid: 0000-0002-8673-3859
  surname: Hu
  fullname: Hu, Chunyan
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 8
  givenname: Yi
  surname: Zhang
  fullname: Zhang, Yi
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 9
  givenname: Ruixin
  surname: Liu
  fullname: Liu, Ruixin
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 10
  givenname: Ruying
  surname: Hu
  fullname: Hu, Ruying
  organization: Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
– sequence: 11
  givenname: Lixin
  surname: Shi
  fullname: Shi, Lixin
  organization: Affiliated Hospital of Guiyang Medical College, Guiyang, China
– sequence: 12
  givenname: Ruizhi
  surname: Zheng
  fullname: Zheng, Ruizhi
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 13
  givenname: Rui
  orcidid: 0000-0003-3736-7909
  surname: Du
  fullname: Du, Rui
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 14
  givenname: Qing
  surname: Su
  fullname: Su, Qing
  organization: Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
– sequence: 15
  givenname: Jiqiu
  surname: Wang
  fullname: Wang, Jiqiu
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 16
  givenname: Yuhong
  surname: Chen
  fullname: Chen, Yuhong
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 17
  givenname: Xuefeng
  orcidid: 0000-0003-3961-9321
  surname: Yu
  fullname: Yu, Xuefeng
  organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
– sequence: 18
  givenname: Li
  surname: Yan
  fullname: Yan, Li
  organization: Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
– sequence: 19
  givenname: Tiange
  orcidid: 0000-0003-0723-489X
  surname: Wang
  fullname: Wang, Tiange
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 20
  givenname: Zhiyun
  surname: Zhao
  fullname: Zhao, Zhiyun
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 21
  givenname: Xiaolin
  surname: Wang
  fullname: Wang, Xiaolin
  organization: Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China
– sequence: 22
  givenname: Qi
  surname: Li
  fullname: Li, Qi
  organization: Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China
– sequence: 23
  givenname: Guijun
  orcidid: 0000-0002-2503-7534
  surname: Qin
  fullname: Qin, Guijun
  organization: The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
– sequence: 24
  givenname: Qin
  surname: Wan
  fullname: Wan, Qin
  organization: The Affiliated Hospital of Southwest Medical University, Luzhou, China
– sequence: 25
  givenname: Gang
  orcidid: 0000-0002-8105-2384
  surname: Chen
  fullname: Chen, Gang
  organization: Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China
– sequence: 26
  givenname: Min
  orcidid: 0000-0003-4464-453X
  surname: Xu
  fullname: Xu, Min
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 27
  givenname: Meng
  surname: Dai
  fullname: Dai, Meng
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 28
  givenname: Di
  surname: Zhang
  fullname: Zhang, Di
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 29
  givenname: Xulei
  surname: Tang
  fullname: Tang, Xulei
  organization: The First Hospital of Lanzhou University, Lanzhou, China
– sequence: 30
  givenname: Guixia
  orcidid: 0000-0001-8107-616X
  surname: Wang
  fullname: Wang, Guixia
  organization: The First Hospital of Jilin University, Changchun, China
– sequence: 31
  givenname: Feixia
  surname: Shen
  fullname: Shen, Feixia
  organization: The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
– sequence: 32
  givenname: Zuojie
  orcidid: 0000-0003-2377-6357
  surname: Luo
  fullname: Luo, Zuojie
  organization: The First Affiliated Hospital of Guangxi Medical University, Nanning, China
– sequence: 33
  givenname: Yingfen
  orcidid: 0000-0002-8456-1678
  surname: Qin
  fullname: Qin, Yingfen
  organization: The First Affiliated Hospital of Guangxi Medical University, Nanning, China
– sequence: 34
  givenname: Li
  orcidid: 0000-0001-7670-8062
  surname: Chen
  fullname: Chen, Li
  organization: Qilu Hospital of Shandong University, Jinan, China
– sequence: 35
  givenname: Yanan
  surname: Huo
  fullname: Huo, Yanan
  organization: Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Nanchang, China
– sequence: 36
  givenname: Qiang
  surname: Li
  fullname: Li, Qiang
  organization: The Second Affiliated Hospital of Harbin Medical University, Harbin, China
– sequence: 37
  givenname: Zhen
  surname: Ye
  fullname: Ye, Zhen
  organization: Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
– sequence: 38
  givenname: Yinfei
  surname: Zhang
  fullname: Zhang, Yinfei
  organization: Central Hospital of Shanghai Jiading District, Shanghai, China
– sequence: 39
  givenname: Chao
  surname: Liu
  fullname: Liu, Chao
  organization: Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, China
– sequence: 40
  givenname: Youmin
  surname: Wang
  fullname: Wang, Youmin
  organization: The First Affiliated Hospital of Anhui Medical University, Hefei, China
– sequence: 41
  givenname: Shengli
  surname: Wu
  fullname: Wu, Shengli
  organization: Karamay Municipal People’s Hospital, Xinjiang, China
– sequence: 42
  givenname: Tao
  orcidid: 0000-0001-6375-3622
  surname: Yang
  fullname: Yang, Tao
  organization: The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
– sequence: 43
  givenname: Huacong
  surname: Deng
  fullname: Deng, Huacong
  organization: The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
– sequence: 44
  givenname: Donghui
  surname: Li
  fullname: Li, Donghui
  organization: Department of Gastrointestinal Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX
– sequence: 45
  givenname: Shenghan
  surname: Lai
  fullname: Lai, Shenghan
  organization: Johns Hopkins University School of Medicine, Baltimore, MD
– sequence: 46
  givenname: Yiming
  surname: Mu
  fullname: Mu, Yiming
  organization: Chinese People’s Liberation Army General Hospital, Beijing, China
– sequence: 47
  givenname: Lulu
  orcidid: 0000-0001-9621-9231
  surname: Chen
  fullname: Chen, Lulu
  organization: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
– sequence: 48
  givenname: Jiajun
  orcidid: 0000-0002-7613-1408
  surname: Zhao
  fullname: Zhao, Jiajun
  organization: Shandong Provincial Hospital affiliated to Shandong University, Jinan, China
– sequence: 49
  givenname: Guowang
  orcidid: 0000-0003-4298-3554
  surname: Xu
  fullname: Xu, Guowang
  organization: Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China
– sequence: 50
  givenname: Guang
  orcidid: 0000-0002-5754-7635
  surname: Ning
  fullname: Ning, Guang
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 51
  givenname: Yufang
  orcidid: 0000-0002-4829-5915
  surname: Bi
  fullname: Bi, Yufang
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
– sequence: 52
  givenname: Weiqing
  orcidid: 0000-0001-6027-3084
  surname: Wang
  fullname: Wang, Weiqing
  organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33355246$$D View this record in MEDLINE/PubMed
BookMark eNplkcFu1DAQhi1URLcLB14AWeICh9A4thOb27LbBaQKKgriGDn2ZNcliRfbAeWB-p443fZSTqPRfP8_o_nP0MngBkDoJcnfFZRW50YXeZYLwZ6gBZGUZ5wzcYIWOWEy41IWp-gshJs8zxkT4hk6pZRyXrBygW5XIThtVbRuwK7F1-DHHn-wHeCVtibgK-_auVODwVcq7v-qCW-m4GE3dkfVTxv3OO4Bf7Ph1-yxgT_QuYMddnhjVQMRAl71LrVfnO_drps09Fbj9d4OENIiM3YxvMdbO5gkCnjrXX_nyNb4Oo5meo6etqoL8OK-LtGP7cX39afs8uvHz-vVZaYpEzFjUhvJNCk4MzmvaA5USgm0AmigVQUlTGhegiQNK9MM2rKqGmPakpRMc6BL9Oboe_Du9wgh1r0NGrpODeDGUBesooyIkoqEvn6E3rjRD-m6RImSSMLTBUv06p4amx5MffC2V36qHwJIwPkR0N6F9NW21jbe_TV6Zbua5PUccT1HXM8RJ8XbR4oH0__Zfwzypo8
CitedBy_id crossref_primary_10_1016_j_jare_2023_11_026
crossref_primary_10_3389_fcimb_2024_1436477
crossref_primary_10_1016_j_jep_2024_118065
crossref_primary_10_1016_j_xcrm_2022_100727
crossref_primary_10_59717_j_xinn_life_2024_100093
crossref_primary_10_1186_s12933_024_02496_5
crossref_primary_10_1155_2022_2391188
crossref_primary_10_3389_fendo_2023_1232132
crossref_primary_10_1016_j_chroma_2024_464827
crossref_primary_10_14336_AD_2022_0817
crossref_primary_10_3389_fnut_2022_930414
crossref_primary_10_1016_j_fbio_2024_104618
crossref_primary_10_3389_fmicb_2022_1029409
crossref_primary_10_3389_fphar_2024_1383896
crossref_primary_10_2147_DMSO_S370492
crossref_primary_10_1038_s41387_024_00315_0
crossref_primary_10_1096_fj_202302558R
crossref_primary_10_3390_nu13041104
crossref_primary_10_1016_j_cca_2024_120004
crossref_primary_10_1111_dom_14683
crossref_primary_10_1016_j_jpba_2022_115139
crossref_primary_10_1093_lifemeta_loaf001
crossref_primary_10_3389_fendo_2024_1430720
crossref_primary_10_1016_j_xcrm_2024_101688
crossref_primary_10_1016_j_jff_2024_106600
crossref_primary_10_1016_j_phrs_2023_106983
crossref_primary_10_3390_metabo11120845
crossref_primary_10_12677_ACM_2023_13122796
crossref_primary_10_1016_j_metabol_2022_155312
crossref_primary_10_1186_s13098_024_01558_8
crossref_primary_10_1371_journal_pone_0303569
crossref_primary_10_3389_fendo_2021_754006
crossref_primary_10_3389_fmicb_2024_1373402
crossref_primary_10_1016_j_neucom_2024_128447
crossref_primary_10_3390_metabo11070453
crossref_primary_10_4239_wjd_v14_i3_255
crossref_primary_10_1111_dom_15104
crossref_primary_10_1210_endrev_bnae025
crossref_primary_10_3390_cells10092437
crossref_primary_10_1007_s12020_024_04115_5
crossref_primary_10_3389_fendo_2022_956203
crossref_primary_10_1080_19490976_2025_2474143
crossref_primary_10_1016_j_ajcnut_2023_08_023
crossref_primary_10_1016_j_jlr_2024_100625
crossref_primary_10_1038_s41467_022_30712_x
crossref_primary_10_1038_s41574_024_01067_8
crossref_primary_10_1038_s41598_023_50304_z
crossref_primary_10_1210_clinem_dgac659
crossref_primary_10_1038_s12276_023_00932_2
crossref_primary_10_1016_j_bcp_2024_116313
crossref_primary_10_1016_j_ajcnut_2024_05_003
crossref_primary_10_2337_dc21_1023
crossref_primary_10_1016_j_foodres_2023_113471
crossref_primary_10_3389_fendo_2021_807318
Cites_doi 10.1038/nm.4358
10.3892/mmr.2016.4761
10.1038/nchembio.1864
10.2337/db13-0639
10.1001/jamacardio.2019.2499
10.2337/dc19-0100
10.1038/nm.2307
10.1016/j.cmet.2016.05.005
10.1007/s12247-014-9182-5
10.1210/jc.2013-3367
10.1111/1753-0407.12858
10.1249/01.MSS.0000078924.61453.FB
10.1111/dom.12648
10.1016/S2213-8587(19)30425-5
10.2337/dc15-2251
10.1002/mnfr.200600162
10.1053/j.gastro.2017.01.055
10.1007/s00125-016-4041-1
10.1038/srep46337
10.1126/science.284.5418.1362
10.1161/CIRCULATIONAHA.109.192703
10.2337/dc18-1390
10.1111/1753-0407.13040
10.1016/j.jacc.2018.09.062
10.1016/S0022-2275(20)38331-0
10.3109/21691401.2015.1069299
10.1111/1753-0407.12108
10.1038/s41467-017-01682-2
10.1371/journal.pgen.1006379
10.1038/nrd2619
10.1016/j.bcp.2013.07.022
10.1038/nrgastro.2017.119
ContentType Journal Article
Copyright 2020 by the American Diabetes Association.
Copyright American Diabetes Association Feb 1, 2021
Copyright_xml – notice: 2020 by the American Diabetes Association.
– notice: Copyright American Diabetes Association Feb 1, 2021
CorporateAuthor 4C Study Group
CorporateAuthor_xml – name: 4C Study Group
DBID AAYXX
CITATION
NPM
K9.
NAPCQ
7X8
DOI 10.2337/dc20-0884
DatabaseName CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
ProQuest Nursing and Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1935-5548
EndPage 510
ExternalDocumentID 33355246
10_2337_dc20_0884
Genre Journal Article
GroupedDBID ---
-ET
..I
.XZ
08P
0R~
18M
29F
2WC
4.4
53G
5GY
5RE
5RS
5VS
6PF
8R4
8R5
AAFWJ
AAIKC
AAMNW
AAWTL
AAYEP
AAYXX
ABOCM
ABPPZ
ACGFO
ACGOD
ADBBV
AEGXH
AENEX
AERZD
AFOSN
AFRAH
AHMBA
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BENPR
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EDB
EMOBN
EX3
F5P
GX1
H13
HZ~
IAO
IEA
IHR
INH
INR
IOF
IPO
KQ8
L7B
M0K
M5~
O5R
O5S
O9-
OK1
OVD
P2P
PCD
Q2X
RHI
SV3
TDI
TEORI
TR2
TWZ
VVN
W8F
WH7
WOQ
WOW
YHG
YOC
ZCG
~KM
.55
.GJ
3O-
3V.
41~
7RV
7X2
7X7
88E
88I
8AF
8AO
8C1
8F7
8FE
8FH
8FI
8FJ
8G5
AAKAS
AAQOH
AAQQT
AAYJJ
ABUWG
ADZCM
AFFNX
AFKRA
AI.
AN0
AQUVI
ATCPS
AZQEC
BCR
BCU
BEC
BHPHI
BKEYQ
BKNYI
BLC
BNQBC
BPHCQ
BVXVI
C1A
CCPQU
DWQXO
EJD
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
IAG
IGG
ITC
J5H
K9-
M0R
M0T
M1P
M2O
M2P
M2Q
N4W
NAPCQ
NPM
PEA
PQQKQ
PROAC
PSQYO
RHF
S0X
SJFOW
UKHRP
VH1
VXZ
WHG
X7M
ZGI
ZXP
K9.
7X8
ID FETCH-LOGICAL-c348t-49cd94c1254d05730e3999e37eebefa23148c56e91b46e39ef677bddf6164c5e3
ISSN 0149-5992
1935-5548
IngestDate Fri Sep 05 14:29:25 EDT 2025
Mon Jun 30 17:05:53 EDT 2025
Wed Feb 19 02:29:47 EST 2025
Tue Jul 01 04:12:03 EDT 2025
Thu Apr 24 23:01:45 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License 2020 by the American Diabetes Association.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c348t-49cd94c1254d05730e3999e37eebefa23148c56e91b46e39ef677bddf6164c5e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-1317-0896
0000-0003-0723-489X
0000-0003-3736-7909
0000-0001-8107-616X
0000-0001-6027-3084
0000-0003-4464-453X
0000-0001-9621-9231
0000-0003-2377-6357
0000-0002-2503-7534
0000-0001-6375-3622
0000-0002-7613-1408
0000-0002-8456-1678
0000-0001-7670-8062
0000-0002-8673-3859
0000-0003-4298-3554
0000-0002-4829-5915
0000-0002-5754-7635
0000-0002-8105-2384
0000-0003-3961-9321
OpenAccessLink https://diabetesjournals.org/care/article-pdf/44/2/499/532040/dc200884.pdf
PMID 33355246
PQID 2486191557
PQPubID 47715
PageCount 12
ParticipantIDs proquest_miscellaneous_2473418638
proquest_journals_2486191557
pubmed_primary_33355246
crossref_citationtrail_10_2337_dc20_0884
crossref_primary_10_2337_dc20_0884
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-02-01
2021-Feb
20210201
PublicationDateYYYYMMDD 2021-02-01
PublicationDate_xml – month: 02
  year: 2021
  text: 2021-02-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Alexandria
PublicationTitle Diabetes care
PublicationTitleAlternate Diabetes Care
PublicationYear 2021
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References Mooranian (2022031300261433700_B27) 2014; 9
Wang (2022031300261433700_B2) 2011; 17
Mooranian (2022031300261433700_B28) 2016; 44
Zhang (2022031300261433700_B29) 2016; 13
Wahlström (2022031300261433700_B4) 2016; 24
Lu (2022031300261433700_B26) 2019; 42
Guasch-Ferré (2022031300261433700_B1) 2016; 39
de Mello (2022031300261433700_B12) 2017; 7
Wang (2022031300261433700_B15) 2019; 4
Zhu (2022031300261433700_B13) 2020; 12
Lu (2022031300261433700_B16) 2018; 72
Haeusler (2022031300261433700_B8) 2013; 62
Sun (2022031300261433700_B3) 2019; 11
Bi (2022031300261433700_B21) 2014; 6
Wang (2022031300261433700_B17) 2020; 8
Devlin (2022031300261433700_B5) 2015; 11
Vaquero (2022031300261433700_B32) 2013; 86
Thomas (2022031300261433700_B24) 2008; 7
Gu (2022031300261433700_B23) 2017; 8
Heuman (2022031300261433700_B25) 1989; 30
Makishima (2022031300261433700_B33) 1999; 284
Jia (2022031300261433700_B6) 2018; 15
Fall (2022031300261433700_B11) 2016; 59
Parsons (2022031300261433700_B18)
Chávez-Talavera (2022031300261433700_B7) 2017; 152
Lloyd-Jones (2022031300261433700_B20) 2010; 121
Nowak (2022031300261433700_B9) 2016; 12
Hansen (2022031300261433700_B30) 2016; 18
Wewalka (2022031300261433700_B10) 2014; 99
Fisher (2022031300261433700_B31) 2007; 51
Lu (2022031300261433700_B14) 2019; 42
Liu (2022031300261433700_B22) 2017; 23
Craig (2022031300261433700_B19) 2003; 35
References_xml – volume: 23
  start-page: 859
  year: 2017
  ident: 2022031300261433700_B22
  article-title: Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention
  publication-title: Nat Med
  doi: 10.1038/nm.4358
– volume: 13
  start-page: 2135
  year: 2016
  ident: 2022031300261433700_B29
  article-title: Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2016.4761
– volume: 11
  start-page: 685
  year: 2015
  ident: 2022031300261433700_B5
  article-title: A biosynthetic pathway for a prominent class of microbiota-derived bile acids
  publication-title: Nat Chem Biol
  doi: 10.1038/nchembio.1864
– volume: 62
  start-page: 4184
  year: 2013
  ident: 2022031300261433700_B8
  article-title: Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids
  publication-title: Diabetes
  doi: 10.2337/db13-0639
– volume: 4
  start-page: 874
  year: 2019
  ident: 2022031300261433700_B15
  article-title: Ideal cardiovascular health metrics and major cardiovascular events in patients with prediabetes and diabetes
  publication-title: JAMA Cardiol
  doi: 10.1001/jamacardio.2019.2499
– volume: 42
  start-page: 2117
  year: 2019
  ident: 2022031300261433700_B26
  article-title: High-coverage targeted lipidomics reveals novel serum lipid predictors and lipid pathway dysregulation antecedent to type 2 diabetes onset in normoglycemic Chinese adults
  publication-title: Diabetes Care
  doi: 10.2337/dc19-0100
– volume: 17
  start-page: 448
  year: 2011
  ident: 2022031300261433700_B2
  article-title: Metabolite profiles and the risk of developing diabetes
  publication-title: Nat Med
  doi: 10.1038/nm.2307
– volume: 24
  start-page: 41
  year: 2016
  ident: 2022031300261433700_B4
  article-title: Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2016.05.005
– volume: 9
  start-page: 150
  year: 2014
  ident: 2022031300261433700_B27
  article-title: Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics
  publication-title: J Pharm Innov
  doi: 10.1007/s12247-014-9182-5
– volume: 99
  start-page: 1442
  year: 2014
  ident: 2022031300261433700_B10
  article-title: Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-3367
– volume: 11
  start-page: 280
  year: 2019
  ident: 2022031300261433700_B3
  article-title: Linking of metabolomic biomarkers with cardiometabolic health in Chinese population
  publication-title: J Diabetes
  doi: 10.1111/1753-0407.12858
– volume: 35
  start-page: 1381
  year: 2003
  ident: 2022031300261433700_B19
  article-title: International physical activity questionnaire: 12-country reliability and validity
  publication-title: Med Sci Sports Exerc
  doi: 10.1249/01.MSS.0000078924.61453.FB
– volume: 18
  start-page: 571
  year: 2016
  ident: 2022031300261433700_B30
  article-title: Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion
  publication-title: Diabetes Obes Metab
  doi: 10.1111/dom.12648
– volume: 8
  start-page: 115
  year: 2020
  ident: 2022031300261433700_B17
  article-title: Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(19)30425-5
– volume: 39
  start-page: 833
  year: 2016
  ident: 2022031300261433700_B1
  article-title: Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis
  publication-title: Diabetes Care
  doi: 10.2337/dc15-2251
– ident: 2022031300261433700_B18
– volume: 51
  start-page: 185
  year: 2007
  ident: 2022031300261433700_B31
  article-title: Candidate gene association study of type 2 diabetes in a nested case-control study of the EPIC-Potsdam cohort -- role of fat assimilation
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.200600162
– volume: 152
  start-page: 1679
  year: 2017
  ident: 2022031300261433700_B7
  article-title: Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2017.01.055
– volume: 59
  start-page: 2114
  year: 2016
  ident: 2022031300261433700_B11
  article-title: Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes
  publication-title: Diabetologia
  doi: 10.1007/s00125-016-4041-1
– volume: 7
  start-page: 46337
  year: 2017
  ident: 2022031300261433700_B12
  article-title: Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study
  publication-title: Sci Rep
  doi: 10.1038/srep46337
– volume: 284
  start-page: 1362
  year: 1999
  ident: 2022031300261433700_B33
  article-title: Identification of a nuclear receptor for bile acids
  publication-title: Science
  doi: 10.1126/science.284.5418.1362
– volume: 121
  start-page: 586
  year: 2010
  ident: 2022031300261433700_B20
  article-title: Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.192703
– volume: 42
  start-page: 1539
  year: 2019
  ident: 2022031300261433700_B14
  article-title: Predictive value of fasting glucose, postload glucose, and hemoglobin A1c on risk of diabetes and complications in Chinese adults
  publication-title: Diabetes Care
  doi: 10.2337/dc18-1390
– volume: 12
  start-page: 616
  year: 2020
  ident: 2022031300261433700_B13
  article-title: Serum total bile acids associate with risk of incident type 2 diabetes and longitudinal changes in glucose-related metabolic traits
  publication-title: J Diabetes
  doi: 10.1111/1753-0407.13040
– volume: 72
  start-page: 3224
  year: 2018
  ident: 2022031300261433700_B16
  article-title: Associations of hemoglobin A1c with cardiovascular disease and mortality in Chinese adults with diabetes
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2018.09.062
– volume: 30
  start-page: 719
  year: 1989
  ident: 2022031300261433700_B25
  article-title: Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions
  publication-title: J Lipid Res
  doi: 10.1016/S0022-2275(20)38331-0
– volume: 44
  start-page: 1642
  year: 2016
  ident: 2022031300261433700_B28
  article-title: Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: formulation characterization and effects on production of insulin and inflammation in a pancreatic β-cell line
  publication-title: Artif Cells Nanomed Biotechnol
  doi: 10.3109/21691401.2015.1069299
– volume: 6
  start-page: 147
  year: 2014
  ident: 2022031300261433700_B21
  article-title: Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study
  publication-title: J Diabetes
  doi: 10.1111/1753-0407.12108
– volume: 8
  start-page: 1785
  year: 2017
  ident: 2022031300261433700_B23
  article-title: Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01682-2
– volume: 12
  start-page: e1006379
  year: 2016
  ident: 2022031300261433700_B9
  article-title: Effect of insulin resistance on monounsaturated fatty acid levels: a multi-cohort non-targeted metabolomics and Mendelian randomization study
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1006379
– volume: 7
  start-page: 678
  year: 2008
  ident: 2022031300261433700_B24
  article-title: Targeting bile-acid signalling for metabolic diseases
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd2619
– volume: 86
  start-page: 926
  year: 2013
  ident: 2022031300261433700_B32
  article-title: Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2013.07.022
– volume: 15
  start-page: 111
  year: 2018
  ident: 2022031300261433700_B6
  article-title: Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2017.119
SSID ssj0004488
Score 2.571944
Snippet Comprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA profile and...
OBJECTIVE Comprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 499
SubjectTerms Acids
Adults
Bile
Bile acids
Chenodeoxycholic acid
Cholesterol
Cholic acid
Correlation analysis
Deoxycholic acid
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Glucose
Health risks
High density lipoprotein
Insulin
Metabolism
Network analysis
Pathogenesis
Regression analysis
Research design
Risk
Taurocholic acid
Tauroursodeoxycholic acid
Title Association of Serum Bile Acids Profile and Pathway Dysregulation With the Risk of Developing Diabetes Among Normoglycemic Chinese Adults: Findings From the 4C Study
URI https://www.ncbi.nlm.nih.gov/pubmed/33355246
https://www.proquest.com/docview/2486191557
https://www.proquest.com/docview/2473418638
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9NAFB7qCuKLeN_qKkfxQSjRbTJJGt9qu3XR3YrSQvEldCaTbqGmsm2Q-hP8H_5Pz5mZ3KTC6ksYJumk5PvmzDkz58LYi9BPvYjPAwdNBe7wlIeO8HxFrYQCP3tRQNHI5-PgdMrfz_xZq_Wz5rWUb8Ur-WNvXMn_oIp9iCtFyf4DsuWg2IFtxBeviDBer4Rx7dvq4BN1mX_tvMV53unLZbKhKADKu2QiAlDV-z7fdYY7XBQXtmgXCgXahkWqfLYu5sMqiGpYbMv2dUGiMWq368VqJ7U7PdXdVpTUhPJ3aLe60VIHyGxQF7YRK3yg3RQbB8floORyVnoD5ZpMS7VaVhv8dh_7IsfWLq-5Di2Nu3_V826u93u_XKhskdluu5Hhdgvf51L2Rp7voHZjxLHa02cFtkkYaYnp1qQvN7WW_lwVXE_nFUikS657piJdM_P2-GM8mp6dxZOT2eQau-6GoT7y__Cplnme6xqm5R8yWapo6NflwE3d5i8Gi1ZcJrfZLWtxQN_Q5w5rqewuu3FufSrusV81FsE6Bc0iIBaBZhFYFgGyCCyLoMEiIBYBIg7EIhqjYhEUgINmETRYBJZFYFj0BgoOAXFIj8gHoDl0n01HJ5PBqWOLdzgSp_jW4ZFMIi5Rf-YJJd08VqgKR8oLFYqNdI5mBe9JP1BRV_AA76k0CEORJGmABrz0lfeAHWTrTB0y8KUQIZce5crjqDGLRLhcCh4dC1wiI7fNXhafPZY2sz0VWFnFaOESQjEhFBNCbfa8fPSbSeey76GjArvYzvZN7PJe0KViCmGbPStvoyymA7Z5ptY5PROiUtjDJa3NHhrMy7d4Hmr2Lg8eXeHXj9nNaoIcsYPtZa6eoO67FU81KX8D-qqyPg
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+Serum+Bile+Acids+Profile+and+Pathway+Dysregulation+With+the+Risk+of+Developing+Diabetes+Among+Normoglycemic+Chinese+Adults%3A+Findings+From+the+4C+Study&rft.jtitle=Diabetes+care&rft.au=Lu%2C+Jieli&rft.au=Wang%2C+Shuangyuan&rft.au=Li%2C+Mian&rft.au=Gao%2C+Zhengnan&rft.date=2021-02-01&rft.issn=1935-5548&rft.eissn=1935-5548&rft.volume=44&rft.issue=2&rft.spage=499&rft_id=info:doi/10.2337%2Fdc20-0884&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon